Value proposition

Innovative nano-antibodies for medical diagnostics. A bilateral partnership between LISM and BioCytex.

Supported by the Agence Nationale de la Recherche (ANR), NVDIAG—short for Nano-antibody generation using extracellular Vesicles for DIAgnostic purposes—is a collaborative laboratory (LabCom) formed through a bilateral partnership between the Laboratoire d’Ingénierie des Systèmes Macromoléculaires (LISM) and BioCytex, both located in Marseille. NVDIAG plays a leading role in advancing innovation in hemato-oncology, focusing on the development of camelid monoclonal antibodies (nano-antibodies) that serve a variety of tests and companion diagnostics solutions.